Skip to content

A Cross-sectional Study on Glycometabolic Reprogramming in Intestinal Epithelial Metaplasia

A Cross-sectional Study on Glycometabolic Reprogramming in Intestinal Epithelial Metaplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093500
Enrollment
Unknown
Registered
2024-12-05
Start date
2024-12-05
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Metaplasia

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age: 18 years or older. No gender restrictions. Positive C13 breath test and CagA-positive based on rapid Helicobacter pylori genotyping using quantum dot technology. Endoscopic diagnosis of chronic atrophic gastritis with intestinal metaplasia and erosion, requiring biopsy. Patients who voluntarily agree to participate in the study.

Exclusion criteria

Exclusion criteria: Presence of cardiovascular diseases, coagulation disorders, metabolic diseases, or mental disorders (e.g., hypertension, heart failure, coronary artery disease, arrhythmia, coagulation dysfunction, diabetes, depression, or a history of tumors). Use of antibiotics or proton pump inhibitors within the past 3 months. History of Helicobacter pylori eradication therapy. Pregnancy or lactation. History of esophageal or gastrointestinal surgery.

Design outcomes

Primary

MeasureTime frame
Glycometabolite;

Countries

China

Contacts

Public ContactChangjiang Hu

The Second Affiliated Hospital of Army Medical University

hcj888@tmmu.edu.cn+86 131 3239 5929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026